David Ng’ang’a

2.1k total citations
5 papers, 115 citations indexed

About

David Ng’ang’a is a scholar working on Epidemiology, Genetics and Oncology. According to data from OpenAlex, David Ng’ang’a has authored 5 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Genetics and 2 papers in Oncology. Recurrent topics in David Ng’ang’a's work include Virus-based gene therapy research (3 papers), Herpesvirus Infections and Treatments (2 papers) and Virology and Viral Diseases (2 papers). David Ng’ang’a is often cited by papers focused on Virus-based gene therapy research (3 papers), Herpesvirus Infections and Treatments (2 papers) and Virology and Viral Diseases (2 papers). David Ng’ang’a collaborates with scholars based in United States, Canada and South Korea. David Ng’ang’a's co-authors include Peter Abbink, Dan H. Barouch, Erica N. Borducchi, Alexander Badamchi-Zadeh, Pablo Penaloza‐MacMaster, Rafael A. Larocca, Malika Aïd, Nicholas M. Provine, Christine A. Bricault and Marinela Kirilova and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and PLoS Pathogens.

In The Last Decade

David Ng’ang’a

5 papers receiving 113 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Ng’ang’a United States	5	49	45	40	28	25	5	115
Lily Parenteau United States	4	67 1.4×	50 1.1×	36 0.9×	18 0.6×	22 0.9×	4	126
Stephen Blackmore United States	6	81 1.7×	53 1.2×	29 0.7×	19 0.7×	27 1.1×	7	163
Juliana C. Small United States	6	35 0.7×	47 1.0×	51 1.3×	21 0.8×	46 1.8×	12	137
Mo Weijtens Netherlands	4	41 0.8×	61 1.4×	75 1.9×	40 1.4×	45 1.8×	6	156
Alexander Badamchi-Zadeh United States	9	81 1.7×	44 1.0×	34 0.8×	41 1.5×	57 2.3×	10	181
Julia Wegner Germany	4	42 0.9×	25 0.6×	27 0.7×	28 1.0×	63 2.5×	6	117
Lara M. Jeworowski Germany	7	47 1.0×	96 2.1×	43 1.1×	34 1.2×	32 1.3×	11	163
Marinela Kirilova United States	4	42 0.9×	32 0.7×	19 0.5×	25 0.9×	24 1.0×	4	99
Victor I. Ayala United States	7	103 2.1×	36 0.8×	15 0.4×	36 1.3×	22 0.9×	9	206
Elizabeth M. Parzych United States	8	89 1.8×	31 0.7×	34 0.8×	29 1.0×	55 2.2×	13	181

Countries citing papers authored by David Ng’ang’a

Since Specialization

Citations

This map shows the geographic impact of David Ng’ang’a's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ng’ang’a with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ng’ang’a more than expected).

Fields of papers citing papers by David Ng’ang’a

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ng’ang’a. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ng’ang’a. The network helps show where David Ng’ang’a may publish in the future.

Co-authorship network of co-authors of David Ng’ang’a

This figure shows the co-authorship network connecting the top 25 collaborators of David Ng’ang’a. A scholar is included among the top collaborators of David Ng’ang’a based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ng’ang’a. David Ng’ang’a is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Larocca, Rafael A., Nicholas M. Provine, Malika Aïd, et al.. (2016). Adenovirus serotype 5 vaccine vectors trigger IL-27–dependent inhibitory CD4 ⁺ T cell responses that impair CD8 ⁺ T cell function. Science Immunology. 1(5). 16 indexed citations

2.

Tartaglia, Lawrence J., Hui‐Wen Chang, Benjamin C. Lee, et al.. (2016). Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences. PLoS Pathogens. 12(2). e1005431–e1005431. 11 indexed citations

3.

Provine, Nicholas M., Rafael A. Larocca, Malika Aïd, et al.. (2016). Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells. The Journal of Immunology. 197(5). 1809–1822. 43 indexed citations

4.

Maxfield, Lori F., Peter Abbink, Kathryn E. Stephenson, et al.. (2015). Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization. Clinical and Vaccine Immunology. 22(11). 1166–1175. 7 indexed citations

5.

Abbink, Peter, Lori F. Maxfield, David Ng’ang’a, et al.. (2014). Construction and Evaluation of Novel Rhesus Monkey Adenovirus Vaccine Vectors. Journal of Virology. 89(3). 1512–1522. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact